Phase II study of leucovorin, 5-fluorouracil and gemcitabine for locally advanced and metastatic pancreatic cancer (FOLFUGEM 2).

[1]  J. Hainsworth,et al.  Randomized phase II comparison of dose-intense gemcitabine: thirty-minute infusion and fixed dose rate infusion in patients with pancreatic adenocarcinoma. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  Daniel G Haller,et al.  Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group Trial E2297. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  J. Pignon,et al.  A randomised trial comparing 5-FU with 5-FU plus cisplatin in advanced pancreatic carcinoma. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

[4]  P. Hammel.  Evolution de la chimiothérapie de l'adénocarcinome du pancréas , 2002 .

[5]  P. Hammel,et al.  Gemcitabine combined with oxaliplatin in advanced pancreatic adenocarcinoma: final results of a GERCOR multicenter phase II study. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  G. Colucci,et al.  Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma , 2002, Cancer.

[7]  P. Ruszniewski,et al.  Phase II trial of bimonthly leucovorin, 5-fluorouracil and gemcitabine for advanced pancreatic adenocarcinoma (FOLFUGEM). , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[8]  S. Barni,et al.  A combination of a fixed dose rate infusion of gemcitabine associated to a bolus 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD). , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

[9]  D. Huhn,et al.  A phase II trial of gemcitabine in combination with 5-fluorouracil (24-hour) and folinic acid in patients with chemonaive advanced pancreatic cancer. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  D. Jaeck,et al.  Gemcitabine and protracted 5-FU for advanced pancreatic cancer. A phase II study. , 2000, Hepato-gastroenterology.

[11]  J. Berlin,et al.  A Phase II Study of Gemcitabine and 5-Fluorouracil in Metastatic Pancreatic Cancer: An Eastern Cooperative Oncology Group Study (E3296) , 2000, Oncology.

[12]  S. Barni,et al.  A combination of gemcitabine and 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD) , 1999, British Journal of Cancer.

[13]  R. Schilsky,et al.  An investigational new drug treatment program for patients with gemcitabine , 1999, Cancer.

[14]  M. Hidalgo,et al.  Phase I-II study of gemcitabine and fluorouracil as a continuous infusion in patients with pancreatic cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  M. Demeure,et al.  Adenocarcinoma of the pancreas , 1998, Cancer.

[16]  J. Gligorov,et al.  [Adenocarcinoma of the pancreas. General characteristics]. , 1998, Presse medicale.

[17]  E. Touboul,et al.  [Adenocarcinoma of the pancreas. Therapeutic strategies]. , 1998, Presse medicale.

[18]  D. V. Von Hoff,et al.  Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  T. Linné,et al.  Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer. , 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

[20]  D. V. Von Hoff,et al.  A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer. , 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

[21]  D. Neuberg,et al.  Protracted intravenous fluorouracil infusion with radiation therapy in the management of localized pancreaticobiliary carcinoma: a phase I Eastern Cooperative Oncology Group Trial. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  Birgir Gudjonsson,et al.  Cancer of the pancreas: 50 years of surgery , 1987, Cancer.

[23]  V. Devita,et al.  Cancer : Principles and Practice of Oncology , 1982 .

[24]  F. Mícek.  [Cancer of the pancreas]. , 1965, Bratislavske lekarske listy.